|
Market Closed -
Borsa Italiana
10:15:00 06/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.080 EUR | -0.46% |
|
+2.86% | -26.53% |
| 28/09 | Laboratorio Farmaceutico Erfo S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 31/08 | Milan in the pink at the open, oil stocks lead the MIB | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.
Number of employees: 47
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 39.47L | 47.41L | 46.21L | 78.61L |
Direct | 6L | 5L | 7L | 9L | 10.88L |
Other | - | 5L | 6L | 6L | 7L |
Medical | - | 1L | 2L | 3L | 4L |
Revenues from Services | 1.12T | - | - | - | - |
Wholesale Sales Revenues | 40.72L | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 46.63L | 50.13L | 52.28L | 53.29L | 89.59L |
France | - | - | 8L | 9L | 9L |
Belgium | - | - | 2L | 2L | 2L |
Other (EU) | - | - | 5T | - | - |
Spain | 8T | 15.4T | 5.17T | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 01/01/2013 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.46% | +2.86% | -31.21% | +13.68% | 1.03Cr | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,20600Cr | |
| +1.43% | +1.11% | +47.73% | +82.08% | 66TCr | |
| +1.07% | -1.21% | +32.99% | +106.31% | 51TCr | |
| -0.36% | -3.25% | +47.17% | +64.58% | 38TCr | |
| -0.14% | -1.87% | +71.05% | +40.63% | 36TCr | |
| -0.78% | -0.52% | +30.57% | +57.98% | 31TCr | |
| -0.80% | -0.21% | +8.54% | +35.56% | 29TCr | |
| +0.03% | -1.20% | +45.89% | +68.76% | 25TCr | |
| -0.41% | -2.22% | +35.24% | +105.68% | 21TCr | |
| Average | -0.12% | -1.10% | +33.24% | +70.27% | 41.8TCr | |
| Weighted average by Cap. | -0.04% | -1.96% | +42.24% | +88.38% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions
